Consequently, it could be postulated that this may lead to enhanced protection from the development and/or progression of autoimmune disease and inflammatory disorders, implicating Ucp3 as a potential target for preventing or ameliorating Th17 cell-mediated autoimmune diseases such as psoriasis and multiple sclerosis. This evidence concerns the gene UCP3 and multiple sclerosis.